Literature DB >> 20008134

Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice.

James P Luyendyk1, Bradley P Sullivan, Grace L Guo, Ruipeng Wang.   

Abstract

Altered hepatic lipid homeostasis, hepatocellular injury, and inflammation are features of nonalcoholic steatohepatitis, which contributes significantly to liver-related morbidity and mortality in the Western population. A collection of inflammatory mediators have been implicated in the pathogenesis of steatohepatitis in mouse models. However, the pathways essential for coordination and amplification of hepatic inflammation and injury caused by steatosis are not completely understood. We tested the hypothesis that tissue factor (TF)-dependent thrombin generation and the thrombin receptor protease activated receptor-1 (PAR-1) contribute to liver inflammation induced by steatosis in mice. Wild-type C57Bl/6J mice fed a diet deficient in methionine and choline for 2 weeks manifested steatohepatitis characterized by increased serum alanine aminotransferase activity, macrovesicular hepatic steatosis, hepatic inflammatory gene expression, and lobular inflammation. Steatohepatitis progression was associated with thrombin generation and hepatic fibrin deposition. Coagulation cascade activation was significantly reduced in low TF mice, which express 1% of normal TF levels. Hepatic triglyceride accumulation was not affected in low TF mice or PAR-1-deficient mice. In contrast, biomarkers of hepatocellular injury, inflammatory gene induction, and hepatic accumulation of macrophages and neutrophils were greatly reduced by TF-deficiency and PAR-1-deficiency. The results suggest that TF-dependent thrombin generation and activation of PAR-1 amplify hepatic inflammation and injury during the pathogenesis of steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20008134      PMCID: PMC2797880          DOI: 10.2353/ajpath.2010.090672

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  58 in total

Review 1.  How the protease thrombin talks to cells.

Authors:  S R Coughlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Gene expression in human NAFLD.

Authors:  Dario Greco; Anna Kotronen; Jukka Westerbacka; Oscar Puig; Perttu Arkkila; Tuula Kiviluoto; Saara Laitinen; Maria Kolak; Rachel M Fisher; Anders Hamsten; Petri Auvinen; Hannele Yki-Järvinen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

Review 3.  The interactions between inflammation and coagulation.

Authors:  Charles T Esmon
Journal:  Br J Haematol       Date:  2005-11       Impact factor: 6.998

4.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

5.  Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice.

Authors:  Patricia E Ganey; James P Luyendyk; Sandra W Newport; Theresa M Eagle; Jane F Maddox; Nigel Mackman; Robert A Roth
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

Review 6.  Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis.

Authors:  Nigel Mackman; Rachel E Tilley; Nigel S Key
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-07       Impact factor: 8.311

7.  Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.

Authors:  Antonio Nocito; Felix Dahm; Wolfram Jochum; Jae Hwi Jang; Panco Georgiev; Michael Bader; Eberhard Ludwig Renner; Pierre-Alain Clavien
Journal:  Gastroenterology       Date:  2007-05-21       Impact factor: 22.682

Review 8.  Fatty liver: a novel component of the metabolic syndrome.

Authors:  Anna Kotronen; Hannele Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-09       Impact factor: 8.311

Review 9.  Hypercoagulation and thrombophilia in liver disease.

Authors:  P G Northup; V Sundaram; M B Fallon; K R Reddy; R A Balogun; A J Sanyal; Q M Anstee; M R Hoffman; Y Ikura; S H Caldwell
Journal:  J Thromb Haemost       Date:  2007-09-24       Impact factor: 5.824

10.  The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.

Authors:  Suleyman Serdar Koca; Ibrahim Halil Bahcecioglu; Orhan Kursat Poyrazoglu; Ibrahim Hanifi Ozercan; Kazim Sahin; Bilal Ustundag
Journal:  Inflammation       Date:  2007-12-08       Impact factor: 4.657

View more
  28 in total

1.  Thrombin promotes diet-induced obesity through fibrin-driven inflammation.

Authors:  Anna K Kopec; Sara R Abrahams; Sherry Thornton; Joseph S Palumbo; Eric S Mullins; Senad Divanovic; Hartmut Weiler; A Phillip Owens; Nigel Mackman; Ashley Goss; Joanne van Ryn; James P Luyendyk; Matthew J Flick
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

Review 2.  Coagulation in liver toxicity and disease: role of hepatocyte tissue factor.

Authors:  Anna K Kopec; James P Luyendyk
Journal:  Thromb Res       Date:  2014-05       Impact factor: 3.944

Review 3.  Tissue factor pathways linking obesity and inflammation.

Authors:  W Ruf; F Samad
Journal:  Hamostaseologie       Date:  2015-01-27       Impact factor: 1.778

Review 4.  Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.

Authors:  Jens J Posma; Steven P Grover; Yohei Hisada; A Phillip Owens; Silvio Antoniak; Henri M Spronk; Nigel Mackman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

5.  Polyphosphate suppresses complement via the terminal pathway.

Authors:  Jovian M Wat; Jonathan H Foley; Michael J Krisinger; Linnette Mae Ocariza; Victor Lei; Gregory A Wasney; Emilie Lameignere; Natalie C Strynadka; Stephanie A Smith; James H Morrissey; Edward M Conway
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

6.  Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.

Authors:  Anna K Kopec; Alfred P Spada; Patricia C Contreras; Nigel Mackman; James P Luyendyk
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

Review 7.  Inflammation, obesity, and thrombosis.

Authors:  Fahumiya Samad; Wolfram Ruf
Journal:  Blood       Date:  2013-10-03       Impact factor: 22.113

8.  Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.

Authors:  Karen M Kassel; Bradley P Sullivan; Wei Cui; Bryan L Copple; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-07-26       Impact factor: 4.307

Review 9.  Role of hemostatic factors in hepatic injury and disease: animal models de-liver.

Authors:  A K Kopec; N Joshi; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2016-05-10       Impact factor: 5.824

10.  From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.

Authors:  Rance Nault; Kelly A Fader; Anna K Kopec; Jack R Harkema; Timothy R Zacharewski; James P Luyendyk
Journal:  Toxicol Sci       Date:  2016-09-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.